Advertisement
UK markets close in 2 hours 43 minutes
  • FTSE 100

    8,089.83
    +49.45 (+0.62%)
     
  • FTSE 250

    19,707.34
    -12.03 (-0.06%)
     
  • AIM

    755.55
    +0.86 (+0.11%)
     
  • GBP/EUR

    1.1665
    +0.0021 (+0.18%)
     
  • GBP/USD

    1.2476
    +0.0013 (+0.11%)
     
  • Bitcoin GBP

    51,081.15
    -2,118.81 (-3.98%)
     
  • CMC Crypto 200

    1,364.45
    -18.12 (-1.31%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • CRUDE OIL

    83.11
    +0.30 (+0.36%)
     
  • GOLD FUTURES

    2,337.70
    -0.70 (-0.03%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • HANG SENG

    17,284.54
    +83.27 (+0.48%)
     
  • DAX

    17,951.90
    -136.80 (-0.76%)
     
  • CAC 40

    8,005.05
    -86.81 (-1.07%)
     

The Global Immunosuppressants Market is expected to grow by $ 6.99 bn during 2022-2026, accelerating at a CAGR of 7.73% during the forecast period

ReportLinker
ReportLinker

Global Immunosuppressants Market 2022-2026 The analyst has been monitoring the immunosuppressants market and it is poised to grow by $ 6. 99 bn during 2022-2026, accelerating at a CAGR of 7.

New York, July 21, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Immunosuppressants Market 2022-2026" - https://www.reportlinker.com/p06293129/?utm_source=GNW
73% during the forecast period. Our report on the immunosuppressants market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by reimbursement policies for kidney transplantation, rising prevalence of autoimmune diseases, and increasing road accidents.
The immunosuppressants market analysis includes the drug class and geographic landscape.

The immunosuppressants market is segmented as below:
By Drug Class
• Corticosteroids
• Monoclonal antibodies
• Others

By Geographical Landscape
• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the high dependency on immunosuppressants for kidney transplantation as one of the prime reasons driving the immunosuppressants market growth during the next few years. Also, increase in use of tissue engineering for generation of implants and rise in disposable income in developing economies will lead to sizable demand in the market.

The analyst presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on immunosuppressants market covers the following areas:
• Immunosuppressants market sizing
• Immunosuppressants market forecast
• Immunosuppressants market industry analysis

This robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading immunosuppressants market vendors that include AbbVie Inc., Accord Healthcare Ltd., Astellas Pharma Inc., Belcher Pharmaceuticals LLC, Bristol Myers Squibb Co., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Intas Pharmaceuticals Ltd., Johnson and Johnson, LEO Pharma AS, Livzon Pharmaceutical Group Inc., Novartis AG, Pfizer Inc., RPG Life Sciences Ltd., Sanofi, Sebela Pharmaceuticals Inc., TFF Pharmaceuticals Inc., and Viatris Inc. Also, the immunosuppressants market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The analyst presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Read the full report: https://www.reportlinker.com/p06293129/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001